Table of Contents

• How Radiation Damages Tissue Long-Term
• Radiation Injuries Treated with HBOT
• Osteoradionecrosis: Bone Death After Cancer Radiation
• The Marx Protocol: HBOT for Dental Surgery After Radiation
• Soft-Tissue Radionecrosis
• Radiation Cystitis: Bladder Damage After Pelvic Radiation
• How HBOT Reverses Radiation Injury
• Clinical Evidence
• Treatment Protocol
• Insurance Coverage
• Frequently Asked Questions
• Radiation Injury Treatment in Los Angeles

TLDR

Radiation therapy is often life-saving, but its effects on healthy tissue continue long after treatment ends. Hyperbaric oxygen therapy is the only FDA-approved treatment that actively reverses radiation-induced tissue damage by stimulating new blood vessel growth in chronically oxygen-deprived tissue. OxygenWell in Sherman Oaks and Calabasas treats osteoradionecrosis, soft-tissue radionecrosis, radiation cystitis, and more, with Medicare and PPO insurance accepted for all FDA-approved radiation injury indications.

How Radiation Damages Tissue Long-Term

Radiation therapy targets rapidly dividing cancer cells, but inevitably affects the surrounding normal tissue as well. While acute effects resolve within weeks of treatment ending, a second category of damage unfolds silently over the following months and years.

Radiation causes progressive, irreversible damage to small blood vessels in the treatment field. This process, called obliterative endarteritis, gradually reduces blood flow to the irradiated tissue. Without oxygen, the tissue cannot repair itself, resist infection, or tolerate surgical intervention.

The result is what hyperbaric medicine physicians call hypoxic-hypovascular-hypocellular tissue: tissue that is oxygen-depleted, vessel-depleted, and cell-depleted. Standard wound care, antibiotics, and surgery all depend on normal tissue biology to work. In irradiated tissue, they frequently fail.

Radiation Injuries Treated with HBOT

The FDA and the Undersea and Hyperbaric Medical Society (UHMS) have approved HBOT for the following radiation injuries - all covered by Medicare and PPO insurance at OxygenWell:

• Osteoradionecrosis (ORN): Death of bone tissue in the radiation field, most commonly the jaw after head and neck cancer treatment.
• Soft-Tissue Radionecrosis (STNR): Breakdown of soft tissue in the radiation field that fails to heal.
• Radiation Cystitis (Hemorrhagic Cystitis): Inflammation and bleeding from the bladder wall after pelvic radiation.
• Radiation Proctitis: Inflammation and bleeding from the rectal wall after pelvic radiation.
• Marx Protocol (Mandibular Osteoradionecrosis Prevention): HBOT before and after dental extractions in patients who have received radiation to the jaw.

Osteoradionecrosis: Bone Death After Cancer Radiation

Osteoradionecrosis (ORN) is one of the most severe late complications of head and neck radiation therapy. The condition develops when radiation-damaged bone loses its blood supply, leaving it unable to remodel, resist infection, or survive the mechanical stresses of everyday function.

ORN occurs most frequently in patients who have received radiation doses above 60 Gy to the head and neck, particularly when the mandible (lower jaw) is within the treatment field. Approximately 3–10% of head and neck cancer survivors develop ORN (Oral Cancer Foundation).

Patients typically present with jaw pain, swelling, exposed bone in the oral cavity, non-healing extraction sockets, trismus, or pathological fracture in severe cases. Symptoms may appear anywhere from a few months to more than a decade after radiation treatment ends.

ORN is classified into three stages. Stage I is superficial, responsive to conservative treatment plus HBOT. Stage II involves deeper cortical bone, requiring HBOT and possible surgical debridement. Stage III involves full-thickness bone involvement or pathological fracture, requiring surgery plus HBOT. Most patients require between 30–90 sessions depending on disease severity.

The Marx Protocol: HBOT for Dental Surgery After Radiation

The Marx Protocol, developed by Dr. Robert Marx at the University of Miami, protects patients who need dental extractions or oral surgery after head and neck radiation from developing ORN.

The protocol consists of 20 sessions of HBOT before surgery to stimulate angiogenesis in the irradiated tissue, followed by the dental extraction or oral surgery, followed by 10 sessions of HBOT after surgery. The original Marx series demonstrated this protocol reduced ORN incidence from 29.9% (surgery alone) to 5.4% (surgery + HBOT) in irradiated patients.

OxygenWell coordinates directly with oral surgeons, maxillofacial surgeons, and oncology teams throughout Los Angeles to schedule Marx Protocol treatment around the planned procedure.

Soft-Tissue Radionecrosis

Soft-tissue radionecrosis (STNR) is the breakdown of skin and subcutaneous tissue in the radiation field. Unlike acute radiation dermatitis, STNR develops months to years after treatment and involves a non-healing wound in tissue with severely compromised vascularity.

Common presentations include non-healing chest wall wounds after breast radiation, non-healing pelvic wounds after prostate or gynecologic cancer radiation, skin breakdown in the head and neck region after ENT cancer radiation, and failure of reconstructive surgical wounds placed in irradiated tissue.

HBOT reverses STNR by restoring the oxygen gradient in the tissue, stimulating angiogenesis, and creating a wound environment capable of supporting cellular repair. Treatment protocols typically run 30–60 sessions.

Radiation Cystitis: Bladder Damage After Pelvic Radiation

Radiation cystitis is a well-documented late complication of pelvic radiation for prostate, cervical, uterine, rectal, and bladder cancers. The bladder's mucosal lining becomes ischemic and friable, producing symptoms ranging from irritative voiding to gross hematuria and life-threatening hemorrhage.

Hemorrhagic cystitis affects an estimated 5–10% of patients who received pelvic radiation doses above 60 Gy. Standard first-line measures address symptoms but do not restore bladder mucosal health, leading to recurrent bleeding episodes.

HBOT drives angiogenesis directly into the ischemic bladder mucosa, restoring vascularity and halting the cycle of bleeding and re-injury. Published series report resolution or significant improvement of hematuria in 76–92% of patients treated with HBOT for radiation cystitis (Swanson Hyperbarics). Treatment protocols typically require 40–60 sessions.

How HBOT Reverses Radiation Injury

Restoration of the oxygen gradient. Irradiated tissue has a flat oxygen gradient. HBOT corrects this by delivering hyperoxygenated plasma into even avascular tissue, restoring the gradient that triggers new vessel growth.

VEGF-driven angiogenesis. Each session of HBOT followed by return to room air creates a hyperoxia-normoxia cycle that amplifies vascular endothelial growth factor (VEGF) signaling. Over 30–60 sessions, this drives measurable new capillary formation - a structural change that persists after treatment ends.

Osteoblast and fibroblast stimulation. HBOT restores the metabolic capacity of osteoblasts and fibroblasts in irradiated tissue, supporting both soft-tissue healing and bone repair.

Immune restoration. HBOT restores the oxidative killing mechanism of phagocytes, reducing bacterial colonization in non-healing wounds and ORN lesions.

Clinical Evidence

Osteoradionecrosis: A systematic review in PMC (NIH) found that HBOT combined with surgery produced significantly better outcomes than surgery alone for Stage II and III ORN.

Marx Protocol: The original Marx series demonstrated a reduction in ORN incidence from 29.9% to 5.4% in irradiated patients requiring dental extractions.

Radiation Cystitis: Multiple institutional series report 76–92% clinical response rates in patients treated with HBOT for hemorrhagic radiation cystitis.

Soft-Tissue Radionecrosis: Clinical series report resolution or significant improvement in over 80% of STNR patients treated with 30–60 HBOT sessions.

Treatment Protocol

Each session runs 90–120 minutes at 2.0–2.4 ATA breathing 100% medical-grade oxygen.

IndicationTypical SessionsNotes Stage I Osteoradionecrosis30 sessionsHBOT alone often sufficient Stage II/III Osteoradionecrosis30 pre-op + 10 post-opCombined with surgical debridement Marx Protocol (dental extraction)20 pre-op + 10 post-opStandard of care for irradiated jaw Soft-Tissue Radionecrosis30–60 sessionsBased on wound response Radiation Cystitis40–60 sessionsBased on symptom response

Insurance Coverage

All radiation injury indications above are FDA-approved for HBOT and covered by Medicare Part B and most private PPO insurance plans. OxygenWell provides complete insurance verification, pre-authorization support, and direct communication with referring physicians.

Frequently Asked Questions

Can HBOT treat radiation damage years after treatment ended? Yes. HBOT can stimulate angiogenesis and restore tissue health even many years after the original radiation treatment, as long as the tissue is still viable.

Does HBOT replace surgery for osteoradionecrosis? For Stage I ORN, HBOT alone produces resolution in the majority of patients. For Stage II and III disease, HBOT works alongside surgical debridement as part of a combined protocol.

My dentist wants to extract a tooth and I had jaw radiation. What should I do? Ask your dentist to refer you to OxygenWell for a hyperbaric consultation before proceeding. The Marx Protocol requires 20 sessions of HBOT before the extraction and 10 after. Do not proceed with extraction without HBOT coverage if you have received radiation to the head and neck.

What cancers commonly lead to radiation injury treated with HBOT?

• Head and neck cancers (ORN, STNR, Marx Protocol)
• Prostate cancer (radiation cystitis, proctitis)
• Cervical, uterine, and ovarian cancers (radiation cystitis, proctitis, STNR)
• Breast cancer (chest wall STNR, compromised reconstructive flaps)
• Bladder cancer (radiation cystitis)
• Rectal cancer (proctitis, pelvic STNR)

Radiation Injury Treatment in Los Angeles

OxygenWell is a physician-owned hyperbaric and regenerative medicine clinic with locations in Sherman Oaks and Calabasas, serving cancer survivors across the greater Los Angeles area. Dr. Beth Meneley, DAOM, and Dr. Erika Kalash, DO, bring over 11 years of clinical hyperbaric experience and 50,000+ supervised sessions to patients with complex radiation injury presentations.

We work directly with oncologists, radiation oncologists, urologists, oral and maxillofacial surgeons, and reconstructive plastic surgeons throughout Los Angeles to coordinate HBOT as part of a patient's broader cancer survivorship care.

For referring physicians: Download our physician referral form or call us directly. We coordinate insurance authorization for all Medicare and PPO-covered radiation injury indications.

For patients and caregivers: If you or a loved one is a cancer survivor experiencing complications from radiation - jaw pain, exposed bone, bladder bleeding, a wound that will not close - contact OxygenWell today to schedule a consultation and verify your insurance benefits.

Book a Consultation | Verify Insurance Coverage | Physician Referral